Although best characterized in chronic cholestatic liver disease, osteopenic bone disease and fracturing are wellrecognized complications of cirrhosis, particularly after liver transplantation. We sought to compare the prevalence of osteopenia and osteoporosis, to assess the effect of orthotopic liver transplantation (OLT) on bone density, and to determine fracture rates before and after OLT in three groups of patients with advanced cirrhosis: patients with cirrhosis from hepatitis C virus ( T he association between osteopenia and various types of liver disease has been described for more than half a century. 1 The clinical course of osteopenia has been best characterized in the chronic cholestatic liver diseases, but is also known to occur in alcoholic, autoimmune, and viral liver disease. 2,3 Before orthotopic liver transplantation (OLT), osteopenia and its more severe form, osteoporosis, are usually asymptomatic. In the early months after liver transplantation, however, an increased rate of bone loss occurs, and the increased osteopenia causes a high incidence of symptomatic fractures. At the time of transplantation, 50% of patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) have osteoporosis, 4 and up to 40% of these patients will sustain spontaneous fractures in the first postoperative year. 5 The main risk for posttransplantation fractures is the presence of pretransplantation osteopenia; therefore, the identification of osteopenic patients at high risk of fracturing is of considerable importance, particularly in the setting of liver transplantation.The relationship between osteopenic bone disease and noncholestatic liver disease is less well defined. Recent reports suggest its possible relationship with viral hepatitis B and C 6 and with end-stage hepatitis C. 7 This study investigates osteopenic bone disease in three groups of patients with advanced cirrhosis: hepatitis C alone (HCV), alcoholic cirrhosis alone (ALD), and cirrhosis caused by hepatitis C and alcohol abuse (HCV؉ALD). The goals of our study were to determine in each of these groups (1) the prevalence of osteopenia and osteoporosis, (2) the early effect of OLT on bone density, and (3) fracture rates before and in the first year after OLT.
Methods
Patient PopulationA total of 841 patients underwent 928 OLTs at the Mayo Clinic, Rochester, MN, between January 1991 and September 2001. All adult recipients undergoing primary liver transplantation with a single cadaver organ were reviewed to identify patients with HCV, ALD, and HCVϩALD. The study was approved by the Mayo Foundation Institutional Review Board.
Diagnostic Criteria for Patient GroupsThe clinical diagnoses were confirmed by review of clinical and psychiatric history, biochemical and serologic testing, and histologic examination of liver biopsy and/or explanted liver. Patients were classified by the presence of all of the following criteria: HCV by (1) presence of anti-HCV and/or HCV RNA by reverse transcriptase polymerase chain reaction (RT-PCR), (2) ...